JNJ logo Johnson & Johnson +
Johnson & Johnson
+

Johnson & Johnson (JNJ) Business News

Track Johnson & Johnson in real time with a live news feed covering Johnson & Johnson stock news, official press releases, company announcements, and an archive of historical Johnson & Johnson news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?

Zacks Investment Research

12:56 PM | Monday | Jul 27, 2026

news photo
Loading...

J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.

Read full article redirect
12:56 PM | Monday | Jul 27, 2026

J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?

Zacks Investment Research

J&J's MedTech growth slowed down in Q2 as Cardiovascular lagged, but new product launches and stronger Vision, Surgery and Orthopedics may lift H2 sales.

Read full article arrow
News Thumbnail
11:40 AM | Monday | Jul 27, 2026

Forget Social Security: 5 Sleep-at-Night Dividend Stocks Retirees Are Using to Replace a Paycheck

24/7 Wall Street

The 2026 Social Security COLA came in at just 2.8%, which is barely keeping pace with a grocery bill, let alone replacing a paycheck.

Read full article arrow
News Thumbnail
4:44 AM | Monday | Jul 27, 2026

If I Only Had $500 to Invest, This Is the ETF I'd Buy Right Now

Fool - Investing News

This value ETF offers a great value for investors right now.

Read full article arrow
News Thumbnail
5:47 AM | Sunday | Jul 26, 2026

Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?

The Motley Fool

These two companies are pharmaceutical giants. Both seem somewhat overvalued at recent levels.

Read full article arrow
News Thumbnail
4:05 AM | Saturday | Jul 25, 2026

Arrowstreet Capital Limited Partnership Sells 1,504,237 Shares of Johnson & Johnson $JNJ

Defense World

Arrowstreet Capital Limited Partnership lessened its stake in Johnson and Johnson (NYSE: JNJ) by 60.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,004,689 shares of the company's stock after selling 1,504,237 shares during the quarter. Arrowstreet Capital Limited Partnership's

Read full article arrow
News Thumbnail
12:16 PM | Friday | Jul 24, 2026

Q2 Earnings: Guidance Upgrades Push These 3 Stocks Higher

Zacks Investment Research

Companies raising guidance, particularly on the earnings front, always deserve some level of attention from investors. Recently, JNJ, GM, and ABT have all raised their outlooks.

Read full article arrow
News Thumbnail
12:00 PM | Friday | Jul 24, 2026

US FDA approves over-the-counter Tylenol combination pill for pain relief

Reuters

The U.S. Food and Drug Administration on Friday approved a nonprescription, fixed-dose pill that ​combines Kenvue's Tylenol with the nonsteroidal anti-inflammatory ‌drug naproxen for up to 12 hours of pain relief.

Read full article arrow
News Thumbnail
11:36 AM | Friday | Jul 24, 2026

J&J's Innovative Medicine Unit Proves Its Resilience in Q2

Zacks Investment Research

JNJ's Innovative Medicine unit posts strong Q2 growth despite Stelara's patent loss. See what's fueling momentum into H2 2026.

Read full article arrow
News Thumbnail
10:15 AM | Friday | Jul 24, 2026

This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It

Fool - Investing News

A name that's often ignored by investors due to its limited historic growth is evolving into a solid income-growth prospect.

Read full article arrow
News Thumbnail
8:30 AM | Friday | Jul 24, 2026

3 Dividend Stocks Baby Boomers Should Own for the Rest of Their Lives

24/7 Wall Street

Baby boomers heading into retirement face a specific math problem: They need income that grows faster than inflation, drawn from businesses stable enough to survive whatever the next decade throws at them.

Read full article arrow
News Thumbnail